Behavioral Intervention for Chronic Migraine
(RLB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a lifestyle behavior program designed to help people manage chronic migraines. Researchers aim to determine if this approach is practical, well-received, and effective in reducing migraine symptoms. The trial will also explore changes in certain molecules in the body in response to this treatment. Participants will be divided into two groups: one receiving virtual therapy (Lifestyle Behavior Protocol) and the other a placebo (an inactive treatment for comparison). Individuals who have experienced chronic migraines for at least a year might be a good fit. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could improve migraine management for many.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to ask the trial organizers for more details.
What prior data suggests that this lifestyle behavior protocol is safe for managing chronic migraine?
Research shows that lifestyle changes, such as improving sleep habits and using relaxation techniques, can help manage migraines. Studies have found that these changes might reduce headache frequency. These methods, which focus on everyday habits like sleep and exercise, are already in use and are generally safe. No reports of serious side effects have emerged from these lifestyle changes. Participants can feel confident that this approach is safe and well-tolerated.12345
Why are researchers excited about this trial?
Researchers are excited about the Behavioral Intervention for Chronic Migraine trial because it explores a non-drug approach to managing migraines, which could offer a new pathway for patients who prefer or require alternatives to medication. Unlike traditional treatments that often rely on pharmaceuticals like triptans or beta-blockers, this trial uses a Lifestyle Behavior Protocol delivered through virtual therapy sessions. This approach could empower patients by focusing on lifestyle changes and behavioral strategies, potentially reducing reliance on medications and minimizing side effects. Additionally, by using virtual therapy, this method increases accessibility, making it easier for individuals to participate and benefit from the intervention without the need for in-person visits.
What evidence suggests that this lifestyle behavior protocol is effective for managing chronic migraine?
Research shows that lifestyle changes can help manage chronic migraines. In this trial, participants in the Virtual Therapy Group will receive a Lifestyle Behavior Protocol, which includes strategies such as improving sleep, regular exercise, and stress management to reduce migraine frequency. Studies have found that these lifestyle changes can significantly impact migraine occurrence. Meanwhile, the Attention Placebo Group will receive a Sham Behavior Protocol. Treatments like cognitive behavioral therapy (CBT) have improved the quality of life for people with migraines, and this trial aims to use these methods to potentially transform chronic migraines into less frequent, occasional ones.13467
Who Is on the Research Team?
Dr. Yohannes W. Woldeamanuel, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults who have been experiencing chronic migraines for at least one year. It's not suitable for individuals with other types of headaches, those under 18, or pregnant women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a lifestyle behavior protocol to manage chronic migraine
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Lifestyle Behavior Protocol
- Sham Behavior Protocol
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Stanford University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator